{"document_type": "article", "snippet": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "type_of_material": "Brief", "web_url": "http://www.nytimes.com/2015/10/02/business/fda-approves-combining-2-cancer-fighting-drugs.html", "subsection_name": null, "blog": [], "section_name": "Business Day", "source": "The New York Times", "pub_date": "2015-10-02T00:00:00Z", "word_count": "138", "slideshow_credits": null, "news_desk": "Business", "byline": {"person": [], "contributor": "", "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS"}, "abstract": "Food and Drug Administration approves two new skin cancer drugs from Bristol-Myers Squibb; drugs Opdivo and Yervoy work by bolstering immune system.", "keywords": [{"value": "Bristol Myers Squibb Company", "rank": "1", "name": "organizations", "is_major": "Y"}, {"value": "Food and Drug Administration", "rank": "2", "name": "organizations", "is_major": "Y"}, {"value": "Skin Cancer", "rank": "3", "name": "subject", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "rank": "4", "name": "subject", "is_major": "Y"}, {"value": "Melanomas", "rank": "5", "name": "subject", "is_major": "N"}], "print_page": "2", "multimedia": [], "lead_paragraph": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "headline": {"kicker": "Business Briefing", "content_kicker": "Business Briefing", "print_headline": "Fda Approves Combining Two Cancer-Fighting Drugs ", "main": "F.D.A. Approves Combining 2 Cancer-Fighting Drugs"}, "_id": "560dcddc38f0d81aa77a5214"}